DOI: 10.36347/sjams.2022.v10i10.009

Pages: 1636-1641

Background: Oral disease is a worldwide problem that causes agony, tooth loss, deformity, and death. Even though acute pseudomembranous candidiasis, or thrush, is the most common oral candidiasis, other types exist and candida infection may present as white and erythematous sores. White lesions include acute pseudomembranous and chronic hyperplastic candidiasis; red lesions include acute and chronic erythematous candidiasis, angular cheilitis, median rhomboid glossitis, and linear gingival erythema. Candida albicans is a major health hazard. This species causes a variety of ailments, from vaginal infections that affect 75% of women at least once to severe hospital infections that cause morbidity and mortality. As a consequence of the COVID-19 epidemic, several patients have suffered ARDS, which threatens superinfections. According to WHO estimates, the total number of confirmed cases will approach 240 million by October 19, 2021, and the cumulative number of fatalities would exceed 4.8 million. SARS-CoV-2 causes lung illness and systemic consequences. Respiratory and heart issues killed several. Candida strains produce invasive fungal infections. In COVID-19, invasive yeast infections (IYIs) are common. Despite COVID-19's immune system failure, no abnormalities in the cellular and humoral immune cells essential to fight Candida have been found. Oral lesion, taste loss, and tooth loss have all been linked to COVID-19. Methods: This study was comparative study. This study comprised 25–90-year-olds diagnosed with moderate to severe COVID-19 and hospitalized in covid ICU at Comilla Medical College Hospital in Bangladesh. The assessment followed inclusion/exclusion criteria. Sample size was obtained using a calculator with a 0.05 standard error and 95% confidence. Chest imaging and RT-PCR confirmed COVID-19. Comparing 100 patients with oral thrush and associated oral issues. Data entry will utilize SPSS and Excel. SPSS 23 will be used for data analysis. Excel and JASP ..